Top

Supportive Care in Cancer

Published in:

Open Access 01-02-2012 | Original Article

The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients

Authors: Franca Warmenhoven, Eric van Rijswijk, Yvonne Engels, Cornelis Kan, Judith Prins, Chris van Weel, Kris Vissers

Published in: Supportive Care in Cancer | Issue 2/2012

Abstract

Purpose

Depression is highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diagnosing depressive disorder in patients with advanced cancer. The aim of this study was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients.

Methods

Patients with advanced metastatic disease, visiting the outpatient palliative care department, were asked to fill out a self-questionnaire containing the Beck Depression Inventory (BDI-II) and a single screening question “Are you feeling depressed?” The mood section of the PRIME-MD was used as a gold standard.

Results

Sixty-one patients with advanced metastatic disease were eligible to be included in the study. Complete data were obtained from 46 patients. The area under the curve of the receiver operating characteristics analysis of the BDI-II was 0.82. The optimal cut-off point of the BDI-II was 16 with a sensitivity of 90% and a specificity of 69%. The single screening question showed a sensitivity of 50% and a specificity of 94%.

Conclusions

The BDI-II seems an adequate screening tool for a depressive disorder in advanced cancer patients. The sensitivity of a single screening question is poor.

Stiefel R, Die TM, Berney A, Olarte JM, Razavi A (2001) Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care. Support Care Cancer 9:477–488PubMedCrossRef

Kelly J, Turner BJ (2009) Depression in advanced physical illness: diagnostic and treatment issues. Med J Aust 190:S90–S93PubMed

Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr (32):57–71

Reeve JL, Lloyd-Williams M, Dowrick C (2008) Revisiting depression in palliative care settings: the need to focus on clinical utility over validity. Palliat Med 22:383–391PubMedCrossRef

Chochinov HM, Kristjanson LJ, Hack TF, Hassard T, McClement S, Harlos M (2007) Burden to others and the terminally ill. J Pain Symptom Manage 34:463–471PubMedCrossRef

Henoch I, Bergman B, Gustafsson M, Gaston-Johansson F, Danielson E (2007) The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer. J Pain Symptom Manage 34:370–379PubMedCrossRef

Hotopf M, Chidgey J, Ddington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 16:81–97PubMedCrossRef

Lo C, Zimmermann C, Rydall A, Walsh A, Jones JM, Moore MJ, Shepherd FA, Gagliese L, Rodin G (2010) Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 28:3084–3089PubMedCrossRef

Jacobsen PB, Donovan KA, Weitzner MA (2003) Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8:229–240PubMed

10.

Raison AH, Miller CL (2003) Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54:283–294PubMedCrossRef

11.

Periyakoil J, Hallenbeck VS (2002) Identifying and managing preparatory grief and depression at the end of life. Am Fam Physician 65:883–890PubMed

12.

Anderson WG, Alexander SC, Rodriguez KL, Jeffreys AS, Olsen MK, Pollak KI, Tulsky JA, Arnold RM (2008) What concerns me is. Expression of emotion by advanced cancer patients during outpatient visits. Support Care Cancer 16:803–811PubMedCrossRef

13.

Pollak KI, Arnold RM, Jeffreys AS, Alexander SC, Olsen MK, Abernethy AP, Sugg SC, Rodriguez KL, Tulsky JA (2007) Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol 25:5748–5752PubMedCrossRef

14.

Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A (1998) How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 83:1640–1651PubMedCrossRef

15.

Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S (1998) Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol 16:1594–1600PubMed

16.

Lloyd-Williams M (2000) Difficulties in diagnosing and treating depression in the terminally ill cancer patient. Postgrad Med J 76:555–558PubMedCrossRef

17.

Barclay S, Wyatt P, Shore S, Finlay I, Grande G, Todd C (2003) Caring for the dying: how well prepared are general practitioners? A questionnaire study in Wales. Palliat Med 17:27–39PubMedCrossRef

18.

Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA (2008) Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev (2):CD005537

19.

Hopko DR, Robertson SM, Carvalho JP (2009) Sudden gains in depressed cancer patients treated with behavioral activation therapy. Behav Ther 40:346–356PubMedCrossRef

20.

Kelly B, McClement S, Chochinov HM (2006) Measurement of psychological distress in palliative care. Palliat Med 20:779–789PubMedCrossRef

21.

Murray SA, Sheikh A, Thomas K (2006) Advance care planning in primary care. BMJ 333:868–869PubMedCrossRef

22.

Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J (2005) Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ 331:884PubMedCrossRef

23.

Mitchell AJ, Kaar S, Coggan C, Herdman J (2008) Acceptability of common screening methods used to detect distress and related mood disorders—preferences of cancer specialists and non-specialists. Psychooncology 17:226–236PubMedCrossRef

24.

Richter P, Werner J, Heerlein A, Kraus A, Sauer H (1998) On the validity of the Beck Depression Inventory. A review. Psychopathology 31:160–168PubMedCrossRef

25.

Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L (2007) Beck Depression Inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care Engl 16:244–250PubMedCrossRef

26.

Vodemaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488CrossRef

27.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef

28.

Hopko DR, Bell JL, Armento ME, Robertson SM, Hunt MK, Wolf NJ, Mullane C (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26:31–51PubMedCrossRef

29.

Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Ref Type: Report

30.

Fraguas R Jr, Henriques SG Jr, De Lucia MS, Iosifescu DV, Schwartz FH, Menezes PR, Gattaz WF, Martins MA (2006) The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord 91:11–17PubMedCrossRef

31.

Leopold KA, Ahles TA, Walch S, Amdur RJ, Mott LA, Wiegand-Packard L, Oxman TE (1998) Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys 42:1105–1112PubMedCrossRef

32.

Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G (2004) Screening for depression in head and neck cancer. Psychooncology 13:269–280PubMedCrossRef

33.

Love AW, Grabsch B, Clarke DM, Bloch S, Kissane DW (2004) Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry 38:526–531PubMedCrossRef

34.

Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry 26:384–389PubMedCrossRef

35.

Chochinov HM, Wilson KG, Enns M, Lander S (1997) “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry 154:674–676PubMed

36.

Noguera A, Centeno C, Carvajal A, Tejedor MA, Urdiroz J, Martinez M (2009) Spanish “fine tuning” of language to describe depression and anxiety. J Palliat Med 12:707–712PubMedCrossRef

Title: The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients
Authors: Franca Warmenhoven
Eric van Rijswijk
Yvonne Engels
Cornelis Kan
Judith Prins
Chris van Weel
Kris Vissers
Publication date: 01-02-2012
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 2/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-1082-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2012

Hispanic adolescents coping with parental cancer

Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer

The unfulfilled promise: a systematic review of interventions to reduce the unmet supportive care needs of cancer patients

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy

Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy

Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer